Composition for macrophage activation

Details Composition for macrophage activation Composition for macrophage activation

1990-04-13

1995-05-16

Johnston, Jill A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530322, 424450, 4241301, 4241941, A61K 3702, C07K 900

Patent

active

054160707

ABSTRACT:
The present invention provides novel lipophilic disaccharide-dipeptide compounds. The compounds of the invention are preferably encapsulated into multilamellar liposomes, which can be formed from phosphatidyl choline and phosphatidyl glycerol. The compounds are effective in activating human monocytes with subsequent destruction of tumor cells. These compounds have acceptable toxicity in anticipated human dosages.

REFERENCES:
patent: 3976544 (1976-08-01), Adam et al.
patent: 4042678 (1977-08-01), Ciorbaru et al.
patent: 4094971 (1978-06-01), Chedid et al.
patent: 4101536 (1978-07-01), Yamumura et al.
patent: 4153684 (1979-05-01), Audibert et al.
patent: 4158052 (1979-06-01), Audibert et al.
patent: 4172125 (1979-10-01), Audibert et al.
patent: 4185089 (1980-01-01), Derrien et al.
patent: 4186194 (1980-01-01), Adam et al.
patent: 4235771 (1980-11-01), Adam et al.
patent: 4256735 (1981-03-01), Durette et al.
patent: 4271151 (1981-06-01), Hotta et al.
patent: 4272524 (1981-06-01), Chedid et al.
patent: 4317771 (1982-03-01), Shiba et al.
patent: 4323559 (1982-04-01), Audibert et al.
patent: 4357322 (1982-11-01), Rooks, III et al.
patent: 4357323 (1982-11-01), Soma et al.
patent: 4370265 (1983-01-01), Adam et al.
patent: 4382080 (1983-05-01), Shiba et al.
patent: 4391800 (1983-07-01), Durette et al.
patent: 4395399 (1983-07-01), Ovchinnikov et al.
patent: 4396607 (1983-08-01), Lefrancier et al.
patent: 4397844 (1983-08-01), Baschang et al.
patent: 4401659 (1983-08-01), Lefrancier et al.
patent: 4406890 (1983-09-01), Tarcsay et al.
patent: 4414204 (1983-11-01), Tarcsay et al.
patent: 4427659 (1984-01-01), Lefrancier et al.
patent: 4435386 (1984-03-01), Ribi et al.
patent: 4436727 (1984-03-01), Ribi et al.
patent: 4436728 (1984-03-01), Ribi et al.
patent: 4446128 (1984-05-01), Baschang et al.
patent: 4461761 (1984-07-01), Lefrancier et al.
patent: 4505899 (1985-03-01), Ribi et al.
patent: 4505900 (1985-03-01), Ribi et al.
patent: 4515891 (1985-05-01), Yokogawa et al.
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4545932 (1985-10-01), Takase et al.
patent: 4770874 (1988-09-01), Allison et al.
patent: 4950645 (1992-08-01), Vosika et al.
T. Andronova, et al., Chem. of Pept. and Prot., 1, 343 (1982).
D. G. Brown et al., Immunotoxicology, A. Belin, et al., Ed; Martin Hijhof, Pub.; 1987, pp. 219-233 Eur. J. Biochem., 143, 359 (1984).
M. Guinand, et al., Eur. J. Biochem., 143, 359 (1984).
W. R. Hargreaves, et al., Biochem., 17, 3759 (1978).
V. T. Ivanov, et al., "Synthesis, Structure and Biological Properties of Glycopeptides Containing the N-Acetyl-Glucosaminyl-O-(1-4)-N-Acetylmuramyl Disaccharide Unit", Proceedings of the Sixteen European Peptide Symposium, Brunfeldt K. ed., Striptor Copenhagen, 1991, pp. 494-500.
N. C. Phillips, et al., Cancer Res., 45, 128 (1985).
S. Sone, et al., Cancer Immunol. Immunother., 12, 203 (1982).
E. Ribi, et al., Ann. N.Y. Acad. Science, U.S.A., 277, 228 (1976).
G. Sava, et al., Cancer Immunol. Immunother., 18, 49 (1984).
G. Sava, et al., Cancer Immunol. Immunother., 15, 84 (1983).
Biological Abstracts, vol. 89, 1990 (Philadelphia, Pa., US) J. G. Vosika et al.: "Immunologic and Toxicologic Study of Disaccharide Tripeptide Glycerol Dipalmitoyl: A New Lipophilic Immunomodulator" (see p. 779, abstract No. 118879 & Mol Boiter 2(1): 50-56 1990.

Affiliated with

Also associated with

Rating

Composition for macrophage activation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for macrophage activation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for macrophage activation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-637721